Galdu-irabazien kontua
ACLARIS THERAPEUTICS, INC.
ACRS
Errendimenduaren laburpena
Egin klik taulako edozein lerrotan grafikoan gehitzeko
milioika USDtan
| Neurria | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Diru-sarrerak
|
7.83 | 18.72 | 31.25 | 29.75 | 13.45 | 13.32 | 16.82 | 13.13 | 1.68 | - | - |
|
Diru-sarreren kostua
|
2.09 | 2.79 | 3.42 | 4.02 | 4.71 | 5.13 | 4.06 | 6.85 | 2.73 | - | - |
|
Irabazi gordina
|
5.74 | 15.93 | 27.83 | 25.73 | 8.73 | 8.19 | 12.77 | 3.24 | 0.48 | - | - |
|
Ustiapen-gastuak
|
74.62 | 56.65 | 130.80 | 103.73 | 67.88 | 52.70 | 92.45 | 138.66 | 72.90 | 48.57 | 20.67 |
|
Ikerketa eta garapena
|
52.65 | 34.45 | 98.38 | 78.60 | 44.26 | 32.17 | 65.30 | 64.42 | 39.79 | 33.48 | 15.34 |
|
Salmentak, orokorrak eta administratiboak
|
21.97 | 22.20 | 32.41 | 25.13 | 23.62 | 20.53 | 27.16 | 48.00 | 33.11 | 15.09 | 5.33 |
|
Beste ustiapen-gastu batzuk
|
- | - | - | - | - | - | - | - | - | - | - |
|
Ustiapen-irabaziak
|
-68.88 | -40.72 | -102.97 | -78.00 | -59.14 | -44.51 | -79.69 | -135.41 | -72.42 | -48.57 | -20.67 |
|
Ez-ustiapeneko diru-sarrerak
|
11.45 | 9.87 | -14.12 | 8.91 | 31.72 | 6.82 | 81.67 | -2.68 | -2.07 | - | - |
|
Interesen diru-sarrerak
|
7.64 | 7.95 | - | - | - | - | - | - | - | - | - |
|
Interesen gastuak
|
- | - | - | - | - | - | - | - | - | - | - |
|
Beste ez-ustiapeneko diru-sarrerak/gastuak
|
- | - | 8.51 | 2.95 | -1.14 | -0.42 | -2.48 | 2.68 | 2.07 | 0.49 | - |
|
Zerga aurreko irabazia
|
-64.92 | -132.07 | -88.85 | -86.91 | -90.87 | -51.20 | -161.35 | -132.74 | -70.35 | -48.08 | - |
|
Zerga-gastua
|
- | 0.00 | -0.37 | 0.00 | 0.00 | -0.32 | 0.00 | 0.00 | -1.83 | - | - |
|
Partaidetza ez-kontrolatzailea
|
- | - | - | - | - | - | - | - | - | - | - |
|
Irabazi garbia
|
-64.92 | -132.07 | -88.48 | -86.91 | -90.87 | -51.02 | -161.35 | -132.74 | -68.52 | -48.08 | -20.56 |
Informazio osagarria
Akzioko datuak, eratorritakoak eta bestelakoak — ez dira galdu-irabazien kontuaren parte
milioika USDtan, bestela adierazi ezean
| Neurria | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Amortizazioa eta balio-galera
|
- | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-68.43 | -39.91 | -102.11 | -77.21 | -58.22 | -43.19 | -73.28 | -133.54 | -72.02 | -48.57 | -20.67 |
|
Akzioko irabazia (oinarrizkoa)
|
-0.53 | -1.71 | -1.27 | -1.33 | -1.60 | - | - | - | - | - | - |
|
EPS diluitua
|
-0.53 | -1.71 | -1.27 | -1.33 | -1.60 | - | - | - | - | - | - |
|
Akzioen batez besteko haztatua
|
122.56 | 77.30 | 69.81 | 65.21 | 56.73 | - | - | - | - | - | - |
|
Akzioen batez besteko haztatu diluitua
|
122.56 | 77.30 | 69.81 | 65.21 | 56.73 | - | - | - | - | - | - |
|
Irabazi globala
|
-64.41 | -131.86 | -87.69 | -87.58 | -91.00 | -51.04 | -161.35 | -132.56 | -68.50 | -48.20 | -20.71 |